Study identifies two possible targets to halt liver damage in NASH

As much as 12 percent of adults in the United States are living with nonalcoholic steatohepatitis (NASH), an aggressive condition that can lead to cirrhosis or liver cancer.

Source link

Related posts

New approaches in viraemic organ transplantation and antiviral therapies


HBV antivirals most commonly prescribed by gastroenterologists, hepatologists


FDA updates Mavyret label for new safety, efficacy data


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy